Global RNAi Medicine Market Growth (Status and Outlook) 2023-2029

March 2023 | 85 pages | ID: G25EF8B5F159EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

The global RNAi Medicine market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for RNAi Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for RNAi Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for RNAi Medicine is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key RNAi Medicine players cover Alnylam Pharmaceuticals, Ionis Pharmaceuticals, Suzhou Ribo Life Science Co.,Ltd., Sirnaomics, GemmaPharma and RiboBio, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

LPI (LP Information)' newest research report, the “RNAi Medicine Industry Forecast” looks at past sales and reviews total world RNAi Medicine sales in 2022, providing a comprehensive analysis by region and market sector of projected RNAi Medicine sales for 2023 through 2029. With RNAi Medicine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world RNAi Medicine industry.

This Insight Report provides a comprehensive analysis of the global RNAi Medicine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on RNAi Medicine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global RNAi Medicine market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for RNAi Medicine and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global RNAi Medicine.

This report presents a comprehensive overview, market shares, and growth opportunities of RNAi Medicine market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• siRNA
• miRNA
• piRNA
• Others

Segmentation by application

• Drug Discovery & Development
• Therapeutics
• Drug Delivery
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Alnylam Pharmaceuticals
• Ionis Pharmaceuticals
• Suzhou Ribo Life Science Co.,Ltd.
• Sirnaomics
• GemmaPharma
• RiboBio

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global RNAi Medicine Market Size 2018-2029
  2.1.2 RNAi Medicine Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 RNAi Medicine Segment by Type
  2.2.1 siRNA
  2.2.2 miRNA
  2.2.3 piRNA
  2.2.4 Others
2.3 RNAi Medicine Market Size by Type
  2.3.1 RNAi Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global RNAi Medicine Market Size Market Share by Type (2018-2023)
2.4 RNAi Medicine Segment by Application
  2.4.1 Drug Discovery & Development
  2.4.2 Therapeutics
  2.4.3 Drug Delivery
  2.4.4 Others
2.5 RNAi Medicine Market Size by Application
  2.5.1 RNAi Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global RNAi Medicine Market Size Market Share by Application (2018-2023)

3 RNAI MEDICINE MARKET SIZE BY PLAYER

3.1 RNAi Medicine Market Size Market Share by Players
  3.1.1 Global RNAi Medicine Revenue by Players (2018-2023)
  3.1.2 Global RNAi Medicine Revenue Market Share by Players (2018-2023)
3.2 Global RNAi Medicine Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RNAI MEDICINE BY REGIONS

4.1 RNAi Medicine Market Size by Regions (2018-2023)
4.2 Americas RNAi Medicine Market Size Growth (2018-2023)
4.3 APAC RNAi Medicine Market Size Growth (2018-2023)
4.4 Europe RNAi Medicine Market Size Growth (2018-2023)
4.5 Middle East & Africa RNAi Medicine Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas RNAi Medicine Market Size by Country (2018-2023)
5.2 Americas RNAi Medicine Market Size by Type (2018-2023)
5.3 Americas RNAi Medicine Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC RNAi Medicine Market Size by Region (2018-2023)
6.2 APAC RNAi Medicine Market Size by Type (2018-2023)
6.3 APAC RNAi Medicine Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe RNAi Medicine by Country (2018-2023)
7.2 Europe RNAi Medicine Market Size by Type (2018-2023)
7.3 Europe RNAi Medicine Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa RNAi Medicine by Region (2018-2023)
8.2 Middle East & Africa RNAi Medicine Market Size by Type (2018-2023)
8.3 Middle East & Africa RNAi Medicine Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RNAI MEDICINE MARKET FORECAST

10.1 Global RNAi Medicine Forecast by Regions (2024-2029)
  10.1.1 Global RNAi Medicine Forecast by Regions (2024-2029)
  10.1.2 Americas RNAi Medicine Forecast
  10.1.3 APAC RNAi Medicine Forecast
  10.1.4 Europe RNAi Medicine Forecast
  10.1.5 Middle East & Africa RNAi Medicine Forecast
10.2 Americas RNAi Medicine Forecast by Country (2024-2029)
  10.2.1 United States RNAi Medicine Market Forecast
  10.2.2 Canada RNAi Medicine Market Forecast
  10.2.3 Mexico RNAi Medicine Market Forecast
  10.2.4 Brazil RNAi Medicine Market Forecast
10.3 APAC RNAi Medicine Forecast by Region (2024-2029)
  10.3.1 China RNAi Medicine Market Forecast
  10.3.2 Japan RNAi Medicine Market Forecast
  10.3.3 Korea RNAi Medicine Market Forecast
  10.3.4 Southeast Asia RNAi Medicine Market Forecast
  10.3.5 India RNAi Medicine Market Forecast
  10.3.6 Australia RNAi Medicine Market Forecast
10.4 Europe RNAi Medicine Forecast by Country (2024-2029)
  10.4.1 Germany RNAi Medicine Market Forecast
  10.4.2 France RNAi Medicine Market Forecast
  10.4.3 UK RNAi Medicine Market Forecast
  10.4.4 Italy RNAi Medicine Market Forecast
  10.4.5 Russia RNAi Medicine Market Forecast
10.5 Middle East & Africa RNAi Medicine Forecast by Region (2024-2029)
  10.5.1 Egypt RNAi Medicine Market Forecast
  10.5.2 South Africa RNAi Medicine Market Forecast
  10.5.3 Israel RNAi Medicine Market Forecast
  10.5.4 Turkey RNAi Medicine Market Forecast
  10.5.5 GCC Countries RNAi Medicine Market Forecast
10.6 Global RNAi Medicine Forecast by Type (2024-2029)
10.7 Global RNAi Medicine Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Alnylam Pharmaceuticals
  11.1.1 Alnylam Pharmaceuticals Company Information
  11.1.2 Alnylam Pharmaceuticals RNAi Medicine Product Offered
  11.1.3 Alnylam Pharmaceuticals RNAi Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Alnylam Pharmaceuticals Main Business Overview
  11.1.5 Alnylam Pharmaceuticals Latest Developments
11.2 Ionis Pharmaceuticals
  11.2.1 Ionis Pharmaceuticals Company Information
  11.2.2 Ionis Pharmaceuticals RNAi Medicine Product Offered
  11.2.3 Ionis Pharmaceuticals RNAi Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Ionis Pharmaceuticals Main Business Overview
  11.2.5 Ionis Pharmaceuticals Latest Developments
11.3 Suzhou Ribo Life Science Co.,Ltd.
  11.3.1 Suzhou Ribo Life Science Co.,Ltd. Company Information
  11.3.2 Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Product Offered
  11.3.3 Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Suzhou Ribo Life Science Co.,Ltd. Main Business Overview
  11.3.5 Suzhou Ribo Life Science Co.,Ltd. Latest Developments
11.4 Sirnaomics
  11.4.1 Sirnaomics Company Information
  11.4.2 Sirnaomics RNAi Medicine Product Offered
  11.4.3 Sirnaomics RNAi Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Sirnaomics Main Business Overview
  11.4.5 Sirnaomics Latest Developments
11.5 GemmaPharma
  11.5.1 GemmaPharma Company Information
  11.5.2 GemmaPharma RNAi Medicine Product Offered
  11.5.3 GemmaPharma RNAi Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 GemmaPharma Main Business Overview
  11.5.5 GemmaPharma Latest Developments
11.6 RiboBio
  11.6.1 RiboBio Company Information
  11.6.2 RiboBio RNAi Medicine Product Offered
  11.6.3 RiboBio RNAi Medicine Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 RiboBio Main Business Overview
  11.6.5 RiboBio Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. RNAi Medicine Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of siRNA
Table 3. Major Players of miRNA
Table 4. Major Players of piRNA
Table 5. Major Players of Others
Table 6. RNAi Medicine Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 7. Global RNAi Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 8. Global RNAi Medicine Market Size Market Share by Type (2018-2023)
Table 9. RNAi Medicine Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 10. Global RNAi Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 11. Global RNAi Medicine Market Size Market Share by Application (2018-2023)
Table 12. Global RNAi Medicine Revenue by Players (2018-2023) & ($ Millions)
Table 13. Global RNAi Medicine Revenue Market Share by Player (2018-2023)
Table 14. RNAi Medicine Key Players Head office and Products Offered
Table 15. RNAi Medicine Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global RNAi Medicine Market Size by Regions 2018-2023 & ($ Millions)
Table 19. Global RNAi Medicine Market Size Market Share by Regions (2018-2023)
Table 20. Global RNAi Medicine Revenue by Country/Region (2018-2023) & ($ millions)
Table 21. Global RNAi Medicine Revenue Market Share by Country/Region (2018-2023)
Table 22. Americas RNAi Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 23. Americas RNAi Medicine Market Size Market Share by Country (2018-2023)
Table 24. Americas RNAi Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 25. Americas RNAi Medicine Market Size Market Share by Type (2018-2023)
Table 26. Americas RNAi Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 27. Americas RNAi Medicine Market Size Market Share by Application (2018-2023)
Table 28. APAC RNAi Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 29. APAC RNAi Medicine Market Size Market Share by Region (2018-2023)
Table 30. APAC RNAi Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 31. APAC RNAi Medicine Market Size Market Share by Type (2018-2023)
Table 32. APAC RNAi Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 33. APAC RNAi Medicine Market Size Market Share by Application (2018-2023)
Table 34. Europe RNAi Medicine Market Size by Country (2018-2023) & ($ Millions)
Table 35. Europe RNAi Medicine Market Size Market Share by Country (2018-2023)
Table 36. Europe RNAi Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 37. Europe RNAi Medicine Market Size Market Share by Type (2018-2023)
Table 38. Europe RNAi Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 39. Europe RNAi Medicine Market Size Market Share by Application (2018-2023)
Table 40. Middle East & Africa RNAi Medicine Market Size by Region (2018-2023) & ($ Millions)
Table 41. Middle East & Africa RNAi Medicine Market Size Market Share by Region (2018-2023)
Table 42. Middle East & Africa RNAi Medicine Market Size by Type (2018-2023) & ($ Millions)
Table 43. Middle East & Africa RNAi Medicine Market Size Market Share by Type (2018-2023)
Table 44. Middle East & Africa RNAi Medicine Market Size by Application (2018-2023) & ($ Millions)
Table 45. Middle East & Africa RNAi Medicine Market Size Market Share by Application (2018-2023)
Table 46. Key Market Drivers & Growth Opportunities of RNAi Medicine
Table 47. Key Market Challenges & Risks of RNAi Medicine
Table 48. Key Industry Trends of RNAi Medicine
Table 49. Global RNAi Medicine Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 50. Global RNAi Medicine Market Size Market Share Forecast by Regions (2024-2029)
Table 51. Global RNAi Medicine Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 52. Global RNAi Medicine Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 53. Alnylam Pharmaceuticals Details, Company Type, RNAi Medicine Area Served and Its Competitors
Table 54. Alnylam Pharmaceuticals RNAi Medicine Product Offered
Table 55. Alnylam Pharmaceuticals RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 56. Alnylam Pharmaceuticals Main Business
Table 57. Alnylam Pharmaceuticals Latest Developments
Table 58. Ionis Pharmaceuticals Details, Company Type, RNAi Medicine Area Served and Its Competitors
Table 59. Ionis Pharmaceuticals RNAi Medicine Product Offered
Table 60. Ionis Pharmaceuticals Main Business
Table 61. Ionis Pharmaceuticals RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 62. Ionis Pharmaceuticals Latest Developments
Table 63. Suzhou Ribo Life Science Co.,Ltd. Details, Company Type, RNAi Medicine Area Served and Its Competitors
Table 64. Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Product Offered
Table 65. Suzhou Ribo Life Science Co.,Ltd. Main Business
Table 66. Suzhou Ribo Life Science Co.,Ltd. RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 67. Suzhou Ribo Life Science Co.,Ltd. Latest Developments
Table 68. Sirnaomics Details, Company Type, RNAi Medicine Area Served and Its Competitors
Table 69. Sirnaomics RNAi Medicine Product Offered
Table 70. Sirnaomics Main Business
Table 71. Sirnaomics RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 72. Sirnaomics Latest Developments
Table 73. GemmaPharma Details, Company Type, RNAi Medicine Area Served and Its Competitors
Table 74. GemmaPharma RNAi Medicine Product Offered
Table 75. GemmaPharma Main Business
Table 76. GemmaPharma RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 77. GemmaPharma Latest Developments
Table 78. RiboBio Details, Company Type, RNAi Medicine Area Served and Its Competitors
Table 79. RiboBio RNAi Medicine Product Offered
Table 80. RiboBio Main Business
Table 81. RiboBio RNAi Medicine Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 82. RiboBio Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. RNAi Medicine Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global RNAi Medicine Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. RNAi Medicine Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. RNAi Medicine Sales Market Share by Country/Region (2022)
Figure 8. RNAi Medicine Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global RNAi Medicine Market Size Market Share by Type in 2022
Figure 10. RNAi Medicine in Drug Discovery & Development
Figure 11. Global RNAi Medicine Market: Drug Discovery & Development (2018-2023) & ($ Millions)
Figure 12. RNAi Medicine in Therapeutics
Figure 13. Global RNAi Medicine Market: Therapeutics (2018-2023) & ($ Millions)
Figure 14. RNAi Medicine in Drug Delivery
Figure 15. Global RNAi Medicine Market: Drug Delivery (2018-2023) & ($ Millions)
Figure 16. RNAi Medicine in Others
Figure 17. Global RNAi Medicine Market: Others (2018-2023) & ($ Millions)
Figure 18. Global RNAi Medicine Market Size Market Share by Application in 2022
Figure 19. Global RNAi Medicine Revenue Market Share by Player in 2022
Figure 20. Global RNAi Medicine Market Size Market Share by Regions (2018-2023)
Figure 21. Americas RNAi Medicine Market Size 2018-2023 ($ Millions)
Figure 22. APAC RNAi Medicine Market Size 2018-2023 ($ Millions)
Figure 23. Europe RNAi Medicine Market Size 2018-2023 ($ Millions)
Figure 24. Middle East & Africa RNAi Medicine Market Size 2018-2023 ($ Millions)
Figure 25. Americas RNAi Medicine Value Market Share by Country in 2022
Figure 26. United States RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 27. Canada RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 28. Mexico RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 29. Brazil RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 30. APAC RNAi Medicine Market Size Market Share by Region in 2022
Figure 31. APAC RNAi Medicine Market Size Market Share by Type in 2022
Figure 32. APAC RNAi Medicine Market Size Market Share by Application in 2022
Figure 33. China RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 34. Japan RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 35. Korea RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 36. Southeast Asia RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 37. India RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 38. Australia RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 39. Europe RNAi Medicine Market Size Market Share by Country in 2022
Figure 40. Europe RNAi Medicine Market Size Market Share by Type (2018-2023)
Figure 41. Europe RNAi Medicine Market Size Market Share by Application (2018-2023)
Figure 42. Germany RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 43. France RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 44. UK RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 45. Italy RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 46. Russia RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 47. Middle East & Africa RNAi Medicine Market Size Market Share by Region (2018-2023)
Figure 48. Middle East & Africa RNAi Medicine Market Size Market Share by Type (2018-2023)
Figure 49. Middle East & Africa RNAi Medicine Market Size Market Share by Application (2018-2023)
Figure 50. Egypt RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 51. South Africa RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 52. Israel RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 53. Turkey RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 54. GCC Country RNAi Medicine Market Size Growth 2018-2023 ($ Millions)
Figure 55. Americas RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 56. APAC RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 57. Europe RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 58. Middle East & Africa RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 59. United States RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 60. Canada RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 61. Mexico RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 62. Brazil RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 63. China RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 64. Japan RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 65. Korea RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 66. Southeast Asia RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 67. India RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 68. Australia RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 69. Germany RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 70. France RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 71. UK RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 72. Italy RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 73. Russia RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 74. Spain RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 75. Egypt RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 76. South Africa RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 77. Israel RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 78. Turkey RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 79. GCC Countries RNAi Medicine Market Size 2024-2029 ($ Millions)
Figure 80. Global RNAi Medicine Market Size Market Share Forecast by Type (2024-2029)
Figure 81. Global RNAi Medicine Market Size Market Share Forecast by Application (2024-2029)